| Prevalence and factors associated with polypharmacy in older people with cancer JP Turner, S Shakib, N Singhal, J Hogan-Doran, R Prowse, S Johns, ... Supportive Care in Cancer 22, 1727-1734, 2014 | 160 | 2014 |
| Polypharmacy cut-points in older people with cancer: how many medications are too many? JP Turner, KM Jamsen, S Shakib, N Singhal, R Prowse, JS Bell Supportive Care in Cancer 24, 1831-1840, 2016 | 139 | 2016 |
| What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals JP Turner, S Edwards, M Stanners, S Shakib, JS Bell BMJ open 6 (3), e009781, 2016 | 128 | 2016 |
| Are residents of aged care facilities willing to have their medications deprescribed? MJ Kalogianis, BC Wimmer, JP Turner, ECK Tan, T Emery, L Robson, ... Research in Social and Administrative Pharmacy 12 (5), 784-788, 2016 | 92 | 2016 |
| An ecological approach to reducing potentially inappropriate medication use: Canadian deprescribing network C Tannenbaum, B Farrell, J Shaw, S Morgan, J Trimble, JC Currie, ... Canadian Journal on Aging/La Revue canadienne du vieillissement 36 (1), 97-107, 2017 | 74 | 2017 |
| Potentially inappropriate medication use in older people with cancer: prevalence and correlates LK Saarelainen, JP Turner, S Shakib, N Singhal, J Hogan-Doran, ... Journal of geriatric oncology 5 (4), 439-446, 2014 | 72 | 2014 |
| A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms E Reeve, F Moriarty, R Nahas, JP Turner, L Kouladjian O’Donnell, ... Expert opinion on drug safety 17 (1), 39-49, 2018 | 71 | 2018 |
| A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review M Sawan, E Reeve, J Turner, A Todd, MA Steinman, M Petrovic, D Gnjidic Expert review of clinical pharmacology 13 (3), 233-245, 2020 | 70 | 2020 |
| Deprescribing: future directions for research W Thompson, E Reeve, F Moriarty, M Maclure, J Turner, MA Steinman, ... Research in Social and Administrative Pharmacy 15 (6), 801-805, 2019 | 69 | 2019 |
| Older adults’ awareness of deprescribing: a population‐based survey JP Turner, C Tannenbaum Journal of the American Geriatrics Society 65 (12), 2691-2696, 2017 | 55 | 2017 |
| Deprescribing conversations: a closer look at prescriber–patient communication JP Turner, C Richard, MT Lussier, ME Lavoie, B Farrell, D Roberge, ... Therapeutic Advances in Drug Safety 9 (12), 687-698, 2018 | 45 | 2018 |
| Cost‐effectiveness of pharmacist‐led Deprescribing of NSAIDs in community‐dwelling older adults C Sanyal, JP Turner, P Martin, C Tannenbaum Journal of the American Geriatrics Society 68 (5), 1090-1097, 2020 | 35 | 2020 |
| Is my older cancer patient on too many medications? JP Turner, S Shakib, JS Bell Journal of geriatric oncology 8 (2), 77-81, 2017 | 35 | 2017 |
| Improving care for elderly patients living with polypharmacy: protocol for a pragmatic cluster randomized trial in community-based primary care practices in Canada M Greiver, S Dahrouge, P O’Brien, D Manca, MT Lussier, J Wang, F Burge, ... Implementation Science 14, 1-15, 2019 | 34 | 2019 |
| Exploration of home care nurse’s experiences in deprescribing of medications: a qualitative descriptive study W Sun, F Tahsin, C Barakat-Haddad, JP Turner, CR Haughian, ... BMJ open 9 (5), e025606, 2019 | 34 | 2019 |
| Patients beliefs and attitudes towards deprescribing: can deprescribing success be predicted? JP Turner, P Martin, YZ Zhang, C Tannenbaum Research in Social and Administrative Pharmacy 16 (4), 599-604, 2020 | 28 | 2020 |
| Economic evaluation of sedative deprescribing in older adults by community pharmacists JP Turner, C Sanyal, P Martin, C Tannenbaum The Journals of Gerontology: Series A 76 (6), 1061-1067, 2021 | 24 | 2021 |
| Policies for deprescribing: an international scan of intended and unintended outcomes of limiting sedative-hypnotic use in community-dwelling older adults J Shaw, AL Murphy, JP Turner, DM Gardner, JL Silvius, Z Bouck, ... Healthcare Policy 14 (4), 39, 2019 | 24 | 2019 |
| Optimising medications for patients with cancer and multimorbidity: the case for deprescribing JP Turner, K Kantilal, HM Holmes, B Koczwara Clinical Oncology 32 (9), 609-617, 2020 | 22 | 2020 |
| Strategies to promote public engagement around deprescribing JP Turner, J Currie, J Trimble, C Tannenbaum Therapeutic advances in drug safety 9 (11), 653-665, 2018 | 20 | 2018 |
Simon BellProfessor, Monash UniversityGeverifieerd e-mailadres voor monash.edu
